Related Experiment Video
Updated: Jun 20, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Helicobacter pylori and non-malignant diseases
Takahisa Furuta1, Jean-Charles Delchier
1Center for Clinical Research, Hamamatsu University School of Medicine, 1-20-1, Handayama, Higashi-Ku, Hamamatsu, Japan. furuta@hama-med.ac.jp
Helicobacter pylori infection is linked to various non-ulcer stomach issues. Eradicating H. pylori infection offers benefits for functional dyspepsia and is recommended for NSAID/aspirin-induced injuries.
Area of Science:
- Gastroenterology
- Microbiology
- Internal Medicine
Background:
- Helicobacter pylori (H. pylori) infection is associated with numerous nonmalignant gastrointestinal disorders.
- Recent research explores inter-individual differences in H. pylori response, influenced by host genetics, bacterial factors, and environment.
Purpose of the Study:
- To review and synthesize current understanding of H. pylori's association with nonmalignant gastrointestinal disorders.
- To highlight recent findings on H. pylori's role in gastritis, peptic ulcer disease, GERD, and NSAID-induced injuries.
Main Methods:
- Literature review of studies published in 2008 concerning H. pylori and nonmalignant disorders.
- Analysis of findings related to host-pathogen interactions and clinical outcomes.
Main Results:
- A decline in H. pylori-related peptic ulcer occurrence was confirmed.
- An inverse relationship between H. pylori infection and gastroesophageal reflux disease (GERD) was confirmed, though gastric atrophy's role is debated.
- H. pylori eradication is recommended for NSAID/aspirin-induced gastric injury and for patients on antiplatelet therapy.
- Eradication provides modest but significant benefit for functional dyspepsia.
Conclusions:
- H. pylori management strategies are evolving, with recommended eradication in specific clinical scenarios.
- Understanding host-pathogen-environment interactions is key to managing H. pylori-associated conditions.
Related Concept Videos
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
